yes, but randomization does not guarantee equivalency of all variables at baseline. its not uncommon for a few baseline parameters to still be skewed despite others being evenly split. the baseline is just such an easy thing to show in the graph that i found it surprising they didnt include it since it would clearly drive home the point of efti's MOA being clinically confirmed.
anyway, i messaged marc and hope he is able to confirm the baseline cd8 was the same for both groups - any pharma partner/acquirer would require this information
otherwise, presentation looks great!
Ann: Immutep Corporate Presentation, page-15
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.5¢ | $694.0K | 2.223M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22530 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 176372 | 4 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |